WO2024038357 - SYNTHESIS OF SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS AND ANALOGUES THEREOF
National phase entry is expected:
Publication Number
WO/2024/038357
Publication Date
22.02.2024
International Application No.
PCT/IB2023/058058
International Filing Date
09.08.2023
Title **
[English]
SYNTHESIS OF SUBSTITUTED TETRACYCLIC CARBOXYLIC ACIDS AND ANALOGUES THEREOF
[French]
SYNTHÈSE D'ACIDES CARBOXYLIQUES TÉTRACYCLIQUES SUBSTITUÉS ET DE LEURS ANALOGUES
Applicants **
ARBUTUS BIOPHARMA CORPORATION
Inventors
CHEN, Shuai
COLE, Andrew G.
GOTCHEV, Dimitar B.
MASON, Jeremy
PALLERLA, Mahesh Kumar
PAMULAPATI, Ganapati Reddy
SPINK, Jan Michelle
Priority Data
63/398,458
16.08.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CIPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3874 | |
| EPO | Filing, Examination, Granting | 55204 | |
| Japan | Filing, Examination, Granting | 3934 | |
| South Korea | Filing, Examination, Granting | 5961 | |
| USA | Filing, Examination, Granting | 14540 |
Total:
83,513
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure includes synthetic methods for preparing certain substituted tetracyclic carboxylic acids, which can be used to treat, ameliorate, or prevent hepatitis B virus (HBV) infections in a patient.[French]
La présente invention comprend des procédés de synthèse pour préparer certains acides carboxyliques tétracycliques substitués, qui peuvent être utilisés pour traiter, améliorer ou prévenir des infections par le virus de l'hépatite B (VHB) chez un patient.